Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells. (1st April 2020)
- Record Type:
- Journal Article
- Title:
- Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells. (1st April 2020)
- Main Title:
- Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells
- Authors:
- Yu, Huilei
Cheng, Jin
Shi, Weili
Ren, Bo
Zhao, Fengyuan
Shi, Yuanyuan
Yang, Peng
Duan, Xiaoning
Zhang, Jiying
Fu, Xin
Hu, Xiaoqing
Ao, Yingfang - Abstract:
- Abstract: Mesenchymal stem cells (MSCs)-derived exosomes are being increasingly focused as the new biological pro-regenerative therapeutic agents for various types of tissue injury. Here, we explored the potential of a novel exosome-based therapeutic application combined with a local fibrin delivery strategy for tendon repair. After discovering that bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exos) promoted the proliferation, migration and tenogenic differentiation of tendon stem/progenitor cells (TSPCs) in vitro, we embedded BMSCs-exos in fibrin and injected it into the defect area of rat patellar tendon, and the results showed that the exosomes could be controlled-released from the fibrin, retained within the defect area, and internalized by TSPCs. BMSCs-exos embedded in fibrin significantly improved the histological scores, enhanced the expression of mohawk, tenomodulin, and type I collagen, as well as the mechanical properties of neotendon, and also promoted the proliferation of local TSPCs in vivo. Overall, we demonstrated the beneficial role of BMSCs-exos in tendon regeneration, and that fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes. This study brings prospects in the potential application of exosomes in novel therapies for tendon injury. Statement of Significance: Mesenchymal stem cells have been identified as a preferred approach in tissue regeneration. In this study, we reported bone marrow mesenchymalAbstract: Mesenchymal stem cells (MSCs)-derived exosomes are being increasingly focused as the new biological pro-regenerative therapeutic agents for various types of tissue injury. Here, we explored the potential of a novel exosome-based therapeutic application combined with a local fibrin delivery strategy for tendon repair. After discovering that bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exos) promoted the proliferation, migration and tenogenic differentiation of tendon stem/progenitor cells (TSPCs) in vitro, we embedded BMSCs-exos in fibrin and injected it into the defect area of rat patellar tendon, and the results showed that the exosomes could be controlled-released from the fibrin, retained within the defect area, and internalized by TSPCs. BMSCs-exos embedded in fibrin significantly improved the histological scores, enhanced the expression of mohawk, tenomodulin, and type I collagen, as well as the mechanical properties of neotendon, and also promoted the proliferation of local TSPCs in vivo. Overall, we demonstrated the beneficial role of BMSCs-exos in tendon regeneration, and that fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes. This study brings prospects in the potential application of exosomes in novel therapies for tendon injury. Statement of Significance: Mesenchymal stem cells have been identified as a preferred approach in tissue regeneration. In this study, we reported bone marrow mesenchymal stem cells (BMSCs) promote the proliferation and migration of tendon stem/progenitor cells (TSPCs) via the paracrine signaling effect of the nanoscale exosomes. We also demonstrated that the application of BMSCs-derived exosomes might be a promising approach to activate the regenerative potential of endogenous TSPCs in tendon injured region, and fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes. Graphical abstract: Image, graphical abstract … (more)
- Is Part Of:
- Acta biomaterialia. Volume 106(2020)
- Journal:
- Acta biomaterialia
- Issue:
- Volume 106(2020)
- Issue Display:
- Volume 106, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 106
- Issue:
- 2020
- Issue Sort Value:
- 2020-0106-2020-0000
- Page Start:
- 328
- Page End:
- 341
- Publication Date:
- 2020-04-01
- Subjects:
- Mesenchymal stem cells -- Exosomes -- TSPCs -- Fibrin glue -- Tendon regeneration
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17427061 ↗
http://www.elsevier.com/wps/find/journaldescription.cws%5Fhome/702994/description ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.actbio.2020.01.051 ↗
- Languages:
- English
- ISSNs:
- 1742-7061
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0602.900500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25850.xml